LB Pharma valued at $382 million as shares jump in New York debut
LBRX shares surged 27% during Nasdaq debut, valued at $381.9 million.
View signal analysisCompany intelligence
LBRX
LBRX
Price—Latest market price
Market cap—Equity value
P / E—Trailing ratio
Volume—Latest session
Market data
TradingViewLBRX price chart
Related signals
1 min delayedLatest LBRX price-moving signals
Browse public LBRX signals with their source context and measured market impact. Open any signal for its permanent analysis page.
LB Pharmaceuticals raises $285 million in US IPO
LB Pharmaceuticals raised $285 million in its IPO, the first sizable biotech IPO since February. This IPO success may increase market confidence in similar biotech firms like LBRX.
View signal analysisLB Pharmaceuticals eyes $322 million valuation in biotech IPO amid sector drought
LBRX targets $321.6 million IPO valuation, indicating strong market interest. This could signal the beginning of biotech recovery in the U.S.
View signal analysisResearch